Home › Stocks › BIOLQ

BIOLQ — BIOLASE INC

Reported value held$50.16K
Funds holding (latest)9
Sector—

BIOLQ (BIOLASE INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 9 funds have reported positions historically, with the sum of their latest reported stakes valued at $50.16K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

FundQuarterSharesValuePortfolio WeightChange
Millennium Management history Q1 2024 116.66K $22.14K 0.00% New
Two Sigma Investments history Q4 2023 10.73K $12.04K 0.00% New
Citadel Advisors history Q1 2024 39.83K $7.56K 0.00% Add
UBS Group AG history Q4 2023 5.62K $6.30K 0.00% New
Vanguard Group history Q1 2024 10.91K $2.07K 0.00% Hold
Bank of America Corp history Q4 2023 23 $26 0.00% Reduce
Morgan Stanley history Q4 2023 14 $16 0.00% Reduce
Wells Fargo & Co history Q1 2024 27 $5 0.00% Add
Fidelity Management & Research (FMR) history Q1 2024 5 $1 0.00% New

New Positions (latest)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 9 funds)

FundQ3 2023Q4 2023Q1 2024
Millennium Management — — 116.66K
Citadel Advisors — 13.82K 39.83K
Vanguard Group — 10.91K 10.91K
Wells Fargo & Co 8 18 27
Fidelity Management & Research (FMR) — — 5
Morgan Stanley 17 14 —
Two Sigma Investments — 10.73K —
Bank of America Corp 41 23 —
UBS Group AG — 5.62K —

Download holders (CSV)